Here, we demonstrate that pharmacological inhibition of GSK3 inhibited NF-κB-mediated inflammation in response to viral infection, but more importantly that this inhibition extends to IRF3-mediated antiviral responses. Here, IRF3 is linked to viral infectious disease.